New Scripps tech helps spot autoimmune disease biomarkers

Scripps Research Institute scientists came up with new technology that they say can successfully be used to screen human blood for biomarkers affecting various autoimmune diseases and other health conditions ranging from multiple sclerosis, lupus, Alzheimer's disease and narcolepsy. Their initial study involved spotting human blood biomarkers for neuromyelitis optica, an autoimmune disorder that is similar to multiple sclerosis and makes sufferers go blind and become paralyzed. And their technique has also worked in mouse studies for multiple sclerosis. One key: a search for peptoids that bind to antibodies found in patients that are known to have a specific disease. Details are published in the journal Chemistry & Biology. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.